Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DR26F7TU5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,041
Award facts
- Contract value 100% obligated
- $21,041.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,041.22 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price delivery order with no set-aside designation, awarded on November 7, 2025, and scheduled for completion by November 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains an extensive portfolio of federal contract awards with the DLA and its Medical Supply Chain. The company has demonstrated capability to meet federal procurement requirements through open competitive processes, with prior awards covering a wide spectrum of pharmaceutical products including diabetes medications, neurological treatments, pain management drugs, antibiotics, and specialized medical supplies. The Ozempic delivery order reflects the company's role in supporting military and veteran healthcare systems through the provision of brand-name medications essential to treating chronic conditions within the Department of Defense healthcare network.
Quick answers
Who was awarded contract SPE2DR26F7TU5?
SPE2DR26F7TU5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F7TU5 worth?
The government has obligated $21,041 on SPE2DR26F7TU5.
Is contract SPE2DR26F7TU5 an order under another contract?
Yes. SPE2DR26F7TU5 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7TU5 competed?
The extent of competition for SPE2DR26F7TU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award